Net income
−$8.9M
−20.7% vs same quarter last year
EPS, diluted
−$0.26
+56.7% vs same quarter last year
Operating cash flow
−$4.4M
−4.4% vs same quarter last year
Operating income
−$10.7M
−40.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $53.7M | $29.8M |
| FY24 | $0 | −$47.7M |
| FY23 | $1.2M | −$53.7M |
| FY22 | $3.2M | −$5M |
| FY21 | $34M | −$95.8M |
| FY20 | $2.7M | −$128.7M |
| FY19 | $1.7M | −$103.9M |
| FY18 | $5.3M | −$55.6M |
| FY17 | - | −$30M |
| FY16 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | 31.5% | 55.5% |
| FY24 | - | - |
| FY23 | −4174.3% | −4645.3% |
| FY22 | −4154.6% | −156% |
| FY21 | −282.4% | −281.9% |
| FY20 | −4821% | −4762.9% |
| FY19 | −6599.2% | −6237.5% |
| FY18 | −1126% | −1044.3% |
| FY17 | - | - |
| FY16 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$33.5M |
| FY24 | −$67.8M |
| FY23 | −$18.7M |
| FY22 | −$114.9M |
| FY21 | −$112.1M |
| FY20 | −$98.1M |
| FY19 | −$113.2M |
| FY18 | −$67.5M |
| FY17 | $4.5M |
| FY16 | - |
- Q32 Bio
- Healthcare median
Show the numbers
| Year | Q32 Bio | Healthcare median |
|---|---|---|
| FY25 | 55.5% | −30.6% |
| FY24 | - | −47% |
| FY23 | −4645.3% | −58% |
| FY22 | −156% | −80.4% |
| FY21 | −281.9% | −71.8% |
| FY20 | −4762.9% | −62.2% |
| FY19 | −6237.5% | −46.2% |
| FY18 | −1044.3% | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |